Advanced Enzyme Technologies
BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
News on Advanced Enzyme Technologies
Advanced Enzyme targets 25-30% CAGR growth
3.41 pm | 14 Feb 2017 | Source: CNBC-TV18
In an interview to CNBC-TV18, CL Rathi, MD of Advanced Enzyme Technologies spoke about the results and his outlook for the company....
Quick Links for Advanced Enzyme Technologies
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.